{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:55:16Z","timestamp":1790873716709,"version":"4.1.0"},"reference-count":268,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["1P01AI073693"],"award-info":[{"award-number":["1P01AI073693"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.smim.2025.101981","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T06:55:58Z","timestamp":1755240958000},"page":"101981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Diffuse neuropsychiatric lupus: Clinical evidence, immune-mediated mechanisms, and therapeutic insights"],"prefix":"10.1016","volume":"79","author":[{"given":"Rachel","family":"Weissman-Tsukamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin R.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-3804","authenticated-orcid":false,"given":"Betty","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2025.101981_bib1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.20999","article-title":"Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort","volume":"52","author":"Alarc\u00f3n-Segovia","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.1780350310","article-title":"A revised estimate of twin concordance in systemic lupus erythematosus","volume":"35","author":"Deafen","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/BOR.0000000000000205","article-title":"Advances in lupus genetics","volume":"27","author":"Niewold","year":"2015","journal-title":"Curr. Opin. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/cells8101180","article-title":"Update on the genetics of systemic lupus erythematosus: Genome-Wide association studies and beyond","volume":"8","author":"Kwon","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.smim.2025.101981_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12016-009-8192-4","article-title":"The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies","volume":"40","author":"Weckerle","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.smim.2025.101981_bib6","article-title":"X-chromosome inactivation altered in SLE","volume":"15","author":"Collison","year":"2019","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cell.2023.12.037","article-title":"Xist ribonucleoproteins promote female sex-biased autoimmunity","volume":"187","author":"Dou","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.smim.2025.101981_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib9","doi-asserted-by":"crossref","unstructured":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42, 599\u20136081999.","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"key":"10.1016\/j.smim.2025.101981_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001133","article-title":"Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus","volume":"6","author":"Elefante","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.smim.2025.101981_bib11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/annrheumdis-2018-214677","article-title":"Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes","volume":"78","author":"Barraclough","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib12","doi-asserted-by":"crossref","first-page":"6290736","DOI":"10.1155\/2022\/6290736","article-title":"Depression-, Pain-, and Health-Related quality of life in patients with systemic lupus erythematosus","volume":"2022","author":"Chalhoub","year":"2022","journal-title":"Int. J. Rheuma."},{"key":"10.1016\/j.smim.2025.101981_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jad.2024.03.121","article-title":"Systemic lupus erythematosus-related brain abnormalities in the default mode network and the limbic system: a resting-state fMRI meta-analysis","volume":"355","author":"Wang","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.smim.2025.101981_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030499","article-title":"Selective involvement of the amygdala in systemic lupus erythematosus","volume":"3","author":"Emmer","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.smim.2025.101981_bib15","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1136\/ard.2009.114157","article-title":"TREX1 gene variant in neuropsychiatric systemic lupus erythematosus","volume":"69","author":"de Vries","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3899\/jrheum.150884","article-title":"Genetic variants that are associated with neuropsychiatric systemic lupus erythematosus","volume":"43","author":"Ho","year":"2016","journal-title":"J. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000835","article-title":"Clinical associations of cognitive dysfunction in systemic lupus erythematosus","volume":"10","author":"Raghunath","year":"2023","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.smim.2025.101981_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196487","article-title":"Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with systemic lupus erythematosus and cognitive dysfunction","volume":"13","author":"Duarte-Garc\u00eda","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2025.101981_bib19","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/ard.2005.049486","article-title":"Hippocampal atrophy in systemic lupus erythematosus","volume":"65","author":"Appenzeller","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib20","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1002\/art.38852","article-title":"Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sj\u00f6gren\u2019s syndrome","volume":"66","author":"Lauvsnes","year":"2014","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.smim.2025.101981_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00062-015-0397-8","article-title":"Global cognitive impairment in systemic lupus erythematosus patients: a structural MRI study","volume":"27","author":"Zimmermann","year":"2017","journal-title":"Clin. Neuroradiol."},{"key":"10.1016\/j.smim.2025.101981_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-215098","article-title":"Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies","author":"Schwarting","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102911","article-title":"Cognitive dysfunction in SLE: an understudied clinical manifestation","volume":"132","author":"Mizrachi","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2025.101981_bib24","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.21271","article-title":"Cerebral and corpus callosum atrophy in systemic lupus erythematosus","volume":"52","author":"Appenzeller","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2014.11.001","article-title":"Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort","volume":"14","author":"Sarbu","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.smim.2025.101981_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0961203317691373","article-title":"Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches","volume":"26","author":"Postal","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WCO.0000000000000822","article-title":"Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus","volume":"33","author":"Mackay","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203313511556","article-title":"In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging","volume":"23","author":"Zimny","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124002","article-title":"Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment","volume":"4","author":"Mackay","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.smim.2025.101981_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.autrev.2017.11.008","article-title":"Brain diffusion tensor MRI in systematic lupus erythematosus: a systematic review","volume":"17","author":"Costallat","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.smim.2025.101981_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-018-1516-0","article-title":"Altered White matter microstructure in lupus patients: a diffusion tensor imaging study","volume":"20","author":"Nystedt","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2025.101981_bib32","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1177\/0961203318793215","article-title":"Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus","volume":"27","author":"Kozora","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1177\/0961203316636471","article-title":"Impaired diffusion tensor imaging findings in the corpus callosum and cingulum May underlie impaired learning and memory abilities in systemic lupus erythematosus","volume":"25","author":"Shapira-Lichter","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1971400918793601","article-title":"White-matter integrity in patients with systemic lupus erythematosus and memory deficits","volume":"31","author":"Corr\u00eaa","year":"2018","journal-title":"Neuroradiol. J."},{"key":"10.1016\/j.smim.2025.101981_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nicl.2014.07.001","article-title":"Diminished White matter integrity in patients with systemic lupus erythematosus","volume":"5","author":"Schmidt-Wilcke","year":"2014","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.smim.2025.101981_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/rheumatology\/keac343","article-title":"Resting state functional connectivity in SLE patients and association with cognitive impairment and blood\u2013brain barrier permeability","volume":"62","author":"Hanly","year":"2022","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.smim.2025.101981_bib37","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/annrheumdis-2020-218004","article-title":"Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment","volume":"79","author":"Kamintsky","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib38","first-page":"470","article-title":"Alterations in Blood-Brain barrier permeability in patients with systemic lupus erythematosus","volume":"40","author":"Chi","year":"2019","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.smim.2025.101981_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/acr.22923","article-title":"Altered Blood-Brain barrier permeability in patients with systemic lupus erythematosus: a novel imaging approach","volume":"69","author":"Gulati","year":"2017","journal-title":"Arthritis. Care Res. Hoboken"},{"key":"10.1016\/j.smim.2025.101981_bib40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/hbm.24837","article-title":"Different patterns of cerebral perfusion in SLE patients with and without neuropsychiatric manifestations","volume":"41","author":"Zhuo","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.smim.2025.101981_bib41","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1177\/0961203319861677","article-title":"Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus","volume":"28","author":"Jia","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib42","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1177\/0961203319887793","article-title":"Regional cerebral perfusion correlates with anxiety in neuropsychiatric SLE: evidence for a mechanism distinct from depression","volume":"28","author":"Papadaki","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1529-0131(200001)43:1<48::AID-ANR7>3.0.CO;2-H","article-title":"Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging","volume":"43","author":"Bosma","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib44","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.10574","article-title":"Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus","volume":"46","author":"Bosma","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nicl.2015.05.002","article-title":"A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus","volume":"8","author":"Ercan","year":"2015","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.smim.2025.101981_bib46","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/art.39653","article-title":"Changes in White matter microstructure suggest an inflammatory origin of neuropsychiatric systemic lupus erythematosus","volume":"68","author":"Magro-Checa","year":"2016","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib47","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J","article-title":"Neuroimaging in neuropsychiatric systemic lupus erythematosus","volume":"42","author":"Sibbitt","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib48","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/0961203307084723","article-title":"Neurometabolic changes in normal White matter May predict appearance of hyperintense lesions in systemic lupus erythematosus","volume":"16","author":"Appenzeller","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib49","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/cne.24656","article-title":"Functional connectivity changes in core resting state networks are associated with cognitive performance in systemic lupus erythematosus","volume":"527","author":"Nystedt","year":"2019","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074530","article-title":"Abnormalities of Frontal-Parietal Resting-State functional connectivity are related to disease activity in patients with systemic lupus erythematosus","volume":"8","author":"Hou","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2025.101981_bib51","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1007\/s12035-016-0050-9","article-title":"Decreased coupling between functional connectivity density and amplitude of low frequency fluctuation in Non-Neuropsychiatric systemic lupus erythematosus: a Resting-Stage functional MRI study","volume":"54","author":"Zhang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.smim.2025.101981_bib52","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/brain.2017.0557","article-title":"Functional connectivity changes in systemic lupus erythematosus: a Resting-State study","volume":"8","author":"Nystedt","year":"2018","journal-title":"Brain Connect"},{"key":"10.1016\/j.smim.2025.101981_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11682-019-00228-y","article-title":"Abnormal topological organization in systemic lupus erythematosus: a resting-state functional magnetic resonance imaging analysis","volume":"15","author":"Cao","year":"2021","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.smim.2025.101981_bib54","doi-asserted-by":"crossref","unstructured":"Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus. doi:10.1002\/hbm.21158.","DOI":"10.1002\/hbm.21158"},{"key":"10.1016\/j.smim.2025.101981_bib55","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1038\/s41380-020-00907-z","article-title":"Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment","volume":"26","author":"Bonacchi","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.smim.2025.101981_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00677","article-title":"A conscious resting state fMRI study in SLE patients without major neuropsychiatric manifestations","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.smim.2025.101981_bib57","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1002\/art.34660","article-title":"Dysfunctional cortico\u2013basal ganglia\u2013thalamic circuit and altered hippocampal\u2013amygdala activity on cognitive set-shifting in non-neuropsychiatric systemic lupus erythematosus","volume":"64","author":"Ren","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib58","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/0961203313480399","article-title":"Learning and memory-related brain activity dynamics are altered in systemic lupus erythematosus: a functional magnetic resonance imaging study","volume":"22","author":"Shapira-Lichter","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib59","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2119\/molmed.2011.00185","article-title":"Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration","volume":"17","author":"Mackay","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.smim.2025.101981_bib60","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/jmri.26006","article-title":"Impaired decision-making and functional neuronal network activity in systemic lupus erythematosus","volume":"48","author":"Wu","year":"2018","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.smim.2025.101981_bib61","doi-asserted-by":"crossref","unstructured":"Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody\u2013Positive Patients. doi:10.1002\/acr.22873.","DOI":"10.1002\/acr.22873"},{"key":"10.1016\/j.smim.2025.101981_bib62","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00296-002-0224-9","article-title":"Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT","volume":"22","author":"Huang","year":"2002","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.smim.2025.101981_bib63","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s100670200126","article-title":"Abnormal regional cerebral blood flow found by Technetium-99m ethyl cysteinate dimer brain single photon emission computed tomography in systemic lupus erythematosus patients with normal brain MRI findings","volume":"21","author":"Chen","year":"2002","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib64","doi-asserted-by":"crossref","unstructured":"Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus. doi:10.1002\/art.23308.","DOI":"10.1002\/art.23308"},{"key":"10.1016\/j.smim.2025.101981_bib65","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1191\/0961203303lu470oa","article-title":"Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage","volume":"12","author":"L\u00f3pez-Longo","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib66","doi-asserted-by":"crossref","unstructured":"Diagnostic value of single-photon\u2013emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: A case-control study. doi:10.1002\/art.21591.","DOI":"10.1002\/art.21591"},{"key":"10.1016\/j.smim.2025.101981_bib67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1529-0131(199901)42:1<61::AID-ANR8>3.0.CO;2-9","article-title":"Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings","volume":"42","author":"Kao","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000074","article-title":"Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus","volume":"2","author":"Mackay","year":"2015","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.smim.2025.101981_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000327","article-title":"Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance","volume":"6","author":"Ploran","year":"2019","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.smim.2025.101981_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000008067","article-title":"Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms","volume":"42","author":"Komatsu","year":"1999","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2017.05.059","article-title":"Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder","volume":"379","author":"Saito","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.smim.2025.101981_bib72","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.59.5.377","article-title":"Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET","volume":"59","author":"Weiner","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib73","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0961203316657432","article-title":"Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [11C]DPA-713 positron emission tomography","volume":"26","author":"Wang","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2008.11.009","article-title":"Depression is an early disease manifestation in lupus-prone MRL\/lpr mice","volume":"207","author":"Gao","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.smim.2025.101981_bib75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0889-1591(92)90048-S","article-title":"A behavioral profile of autoimmune lupus-prone MRL mice","volume":"6","author":"\u0160aki\u0107","year":"1992","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.smim.2025.101981_bib76","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0031-9384(94)90309-3","article-title":"Disturbed emotionality in autoimmune MRL-lpr mice","volume":"56","author":"\u0160aki\u0107","year":"1994","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.smim.2025.101981_bib77","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/art.1780370617","article-title":"Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus","volume":"37","author":"Vogelweid","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib78","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.24523","article-title":"Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus","volume":"60","author":"Sled","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib79","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-5728(98)00085-X","article-title":"Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice","volume":"87","author":"\u0160aki\u0107","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.smim.2025.101981_bib80","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbi.2009.10.009","article-title":"Intrathecal antibodies and brain damage in autoimmune MRL mice","volume":"24","author":"Stanojcic","year":"2010","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.smim.2025.101981_bib81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(01)03060-8","article-title":"Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice","volume":"920","author":"Maric","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.smim.2025.101981_bib82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-024-03085-9","article-title":"Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL\/lpr mouse model of neuropsychiatric lupus","volume":"21","author":"Reynolds","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.smim.2025.101981_bib83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2006.06.023","article-title":"Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice","volume":"179","author":"Ma","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.smim.2025.101981_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02189","article-title":"Neuropsychiatric systemic lupus erythematosus is dependent on Sphingosine-1-Phosphate signaling","volume":"9","author":"Mike","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2025.101981_bib85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11926-021-00992-1","article-title":"Cognitive impairment in SLE: mechanisms and therapeutic approaches","volume":"23","author":"Zarfeshani","year":"2021","journal-title":"Curr. Rheuma Rep."},{"key":"10.1016\/j.smim.2025.101981_bib86","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0021-9975(08)80122-3","article-title":"Clinical neurology and brain histopathology in NZB\/NZW F1 lupus mice","volume":"102","author":"Kier","year":"1990","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.smim.2025.101981_bib87","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/brbi.1996.0023","article-title":"Anxiety behavior, exploratory behavior, and activity in NZB x NZW F1 hybrid mice: role of genotype and autoimmune disease progression","volume":"10","author":"Schrott","year":"1996","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.smim.2025.101981_bib88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(99)00737-5","article-title":"Altered levels of neuropeptides characterize the brain of lupus prone mice","volume":"275","author":"Bracci-Laudiero","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.smim.2025.101981_bib89","first-page":"443","article-title":"Abnormal increase of neuronal precursor cells and exacerbated neuroinflammation in the corpus callosum in murine model of systemic lupus erythematosus","volume":"34","author":"Wai-Hin Leung","year":"2016","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.smim.2025.101981_bib90","doi-asserted-by":"crossref","unstructured":"Karnopp, T.E., Chapacais, G.F., Freitas, E.C. & Monticielo, O.A. Lupus animal models and neuropsychiatric implications. (2020) doi:10.1007\/s10067-020-05493-7.","DOI":"10.1007\/s10067-020-05493-7"},{"key":"10.1016\/j.smim.2025.101981_bib91","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/ard-2022-223506","article-title":"Microglia activation in the presence of intact blood-brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus","volume":"82","author":"Nikolopoulos","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(90)91737-2","article-title":"Brain abnormalities in immune defective mice","volume":"532","author":"Sherman","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.smim.2025.101981_bib93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2018.08.005","article-title":"Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus","volume":"96","author":"Mike","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2025.101981_bib94","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1172\/JCI5827","article-title":"Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies","volume":"103","author":"Mohan","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2025.101981_bib95","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1242\/dmm.016451","article-title":"Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus","volume":"7","author":"Crampton","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.smim.2025.101981_bib96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(01)00412-X","article-title":"Immunoglobulin binding to brain in autoimmune mice","volume":"120","author":"Zameer","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.smim.2025.101981_bib97","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuroscience.2005.06.069","article-title":"Effects of systemic lupus erythematosus on spatial cognition and cerebral regional metabolic reactivity in BxSB lupus-prone mice","volume":"135","author":"Arabo","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.smim.2025.101981_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00230","article-title":"A novel Microglia-Specific transcriptional signature correlates with behavioral deficits in neuropsychiatric lupus","volume":"11","author":"Makinde","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2025.101981_bib99","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10067-017-3811-6","article-title":"Pristane-induced lupus: considerations on this experimental model","volume":"36","author":"Freitas","year":"2017","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib100","doi-asserted-by":"crossref","unstructured":"Luciano-Jaramillo, J. et al. Downregulation of hippocampal NR2A\/2B subunits related to cognitive impairment in a pristane-induced lupus BALB\/c mice. (2019) doi:10.1371\/journal.pone.0217190.","DOI":"10.1101\/631879"},{"key":"10.1016\/j.smim.2025.101981_bib101","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10067-022-06094-2","article-title":"Higher IgG level correlated with vitamin d receptor in the hippocampus of a pristane-induced lupus model","volume":"41","author":"Karnopp","year":"2022","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib102","doi-asserted-by":"crossref","first-page":"uxae099","DOI":"10.1093\/cei\/uxae099","article-title":"The role of vitamin D: a promising pathway to combat neuropsychiatric lupus disorders","volume":"219","author":"Karnopp","year":"2025","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.smim.2025.101981_bib103","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1191\/0961203302lu255oa","article-title":"Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies","volume":"11","author":"Shrot","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib104","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/nan.12180","article-title":"Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones","volume":"41","author":"Frauenknecht","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.smim.2025.101981_bib105","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.imbio.2012.06.011","article-title":"Neurological impairment in experimental antiphospholipid syndrome is associated with increased ligand binding to hippocampal and cortical serotonergic 5-HT1A receptors","volume":"218","author":"Frauenknecht","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.smim.2025.101981_bib106","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2014.04.003","article-title":"Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice","volume":"272","author":"Katzav","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.smim.2025.101981_bib107","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.38900","article-title":"Anti-ribosomal p protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice","volume":"67","author":"Bravo-Zehnder","year":"2015","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib108","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by anti-ribosomal p antibodies via the limbic system","volume":"56","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib109","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41467-020-15224-w","article-title":"Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory","volume":"11","author":"Chan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2025.101981_bib110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity: antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2025.101981_bib111","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.smim.2025.101981_bib112","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"103","author":"Huerta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.smim.2025.101981_bib113","doi-asserted-by":"crossref","first-page":"18569","DOI":"10.1073\/pnas.1006980107","article-title":"Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms","volume":"107","author":"Faust","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.smim.2025.101981_bib114","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/jcbfm.2014.85","article-title":"Regional brain metabolism in a murine systemic lupus erythematosus model","volume":"34","author":"Vo","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.smim.2025.101981_bib115","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ebiom.2015.05.027","article-title":"Selective impairment of spatial cognition caused by autoantibodies to the N-Methyl-d-Aspartate receptor","volume":"2","author":"Chang","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.smim.2025.101981_bib116","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20180776","article-title":"Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors","volume":"215","author":"Nestor","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2025.101981_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-024-01772-6","article-title":"Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression","author":"Carroll","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2025.101981_bib118","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41584-024-01163-z","article-title":"Recent advances in the diagnosis and management of neuropsychiatric lupus","volume":"20","author":"Legge","year":"2024","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib119","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/art.40933","article-title":"Cognitive dysfunction in systemic lupus erythematosus: a case for initiating trials","volume":"71","author":"Kello","year":"2019","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semarthrit.2018.02.007","article-title":"What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis","volume":"48","author":"Rayes","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib121","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41584-021-00692-1","article-title":"Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research","volume":"17","author":"Davies","year":"2021","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib122","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12026-015-8716-3","article-title":"Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus","volume":"63","author":"Mackay","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.smim.2025.101981_bib123","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/09612033211062530","article-title":"Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus","volume":"31","author":"Yuen","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib124","doi-asserted-by":"crossref","unstructured":"Validity Evid ence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus. doi:10.1002\/acr.24096.","DOI":"10.1002\/acr.24096"},{"key":"10.1016\/j.smim.2025.101981_bib125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.semarthrit.2021.05.018","article-title":"Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: a systematic review","volume":"51","author":"Yuen","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib126","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/0961203314555538","article-title":"Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus","volume":"24","author":"Massardo","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib127","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5114\/reum.2015.53134","article-title":"Cambridge neuropsychological test automated battery in assessment of cognitive parameters in patients with systemic lupus erythematosus in relation to autoantibody profile","volume":"53","author":"Bogaczewicz","year":"2015","journal-title":"Reumatologia"},{"key":"10.1016\/j.smim.2025.101981_bib128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejr.2012.02.002","article-title":"Cognitive impairment in non-neuropsychiatric systemic lupus erythematosus","volume":"34","author":"El-Shafey","year":"2012","journal-title":"Egypt. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib129","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/0961203311405374","article-title":"Cognitive dysfunction in SLE: development of a screening tool","volume":"20","author":"Adhikari","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2015.11.052","article-title":"Executive dysfunction, obsessive\u2013compulsive symptoms, and attention deficit and hyperactivity disorder in systemic lupus erythematosus: evidence for basal ganglia dysfunction?","volume":"360","author":"Maciel","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.smim.2025.101981_bib131","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jpsychires.2008.04.014","article-title":"A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment","volume":"43","author":"Mitchell","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.smim.2025.101981_bib132","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/0961203307079044","article-title":"Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials","volume":"16","author":"Mikdashi","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib133","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.10457","article-title":"Systemic lupus erythematosus in three ethnic groups. X. measuring cognitive impairment with the cognitive symptoms inventory","volume":"47","author":"Alarc\u00f3n","year":"2002","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.smim.2025.101981_bib134","first-page":"1459","article-title":"Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"32","author":"Hanly","year":"2005","journal-title":"J. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib135","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3899\/jrheum.161125","article-title":"Performance of screening tests for cognitive impairment in systemic lupus erythematosus","volume":"44","author":"Nantes","year":"2017","journal-title":"J. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib136","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3899\/jrheum.180831","article-title":"Fatigue measurements in systemic lupus erythematosus","volume":"46","author":"Barbacki","year":"2019","journal-title":"J. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib137","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/0961203313476360","article-title":"Qualitative validation of the FACIT-fatigue scale in systemic lupus erythematosus","volume":"22","author":"Kosinski","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib138","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/ijd.15341","article-title":"Measuring fatigue: a meta-review","volume":"60","author":"Machado","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.smim.2025.101981_bib139","article-title":"Reliability, responsiveness, and validity of the visual analog fatigue scale to measure exertion fatigue in people with chronic stroke: a preliminary study","volume":"2010","author":"Tseng","year":"2010","journal-title":"Stroke Res. Treat."},{"key":"10.1016\/j.smim.2025.101981_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2019.01713","article-title":"Psychometric properties of the general anxiety disorder 7-Item (GAD-7) scale in a heterogeneous psychiatric sample","volume":"10","author":"Johnson","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.smim.2025.101981_bib141","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0887-6185(92)90026-4","article-title":"Reliability and validity of the beck anxiety inventory","volume":"6","author":"Fydrich","year":"1992","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.smim.2025.101981_bib142","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.smim.2025.101981_bib143","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/ps.49.1.55","article-title":"A Ten-Year review of the validity and clinical utility of depression screening","volume":"49","author":"Schade","year":"1998","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.smim.2025.101981_bib144","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A RATING SCALE FOR DEPRESSION","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.smim.2025.101981_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2010.12.007","article-title":"Reliability of the hamilton rating scale for depression: a meta-analysis over a period of 49 years","volume":"189","author":"Trajkovi\u0107","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.smim.2025.101981_bib146","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"& and the patient health questionnaire primary care study group. Validation and utility of a Self-report version of PRIME-MDThe PHQ primary care study","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.smim.2025.101981_bib147","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.genhosppsych.2005.07.003","article-title":"Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population","volume":"28","author":"Martin","year":"2006","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.smim.2025.101981_bib148","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/clinpract14020037","article-title":"Anxiety and depression and associated risk factors among outpatients with systemic lupus erythematosus: eastern province, Saudi Arabia","volume":"14","author":"Hasan","year":"2024","journal-title":"Clin. Pr."},{"key":"10.1016\/j.smim.2025.101981_bib149","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4088\/JCP.11r07425","article-title":"Psychiatric symptoms in systemic lupus erythematosus: a systematic review","volume":"73","author":"Meszaros","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.smim.2025.101981_bib150","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000473","article-title":"Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study","volume":"8","author":"Antypa","year":"2021","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.smim.2025.101981_bib151","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/biomedicines12030484","article-title":"One-Year outcomes for depression and anxiety in SLE patients","volume":"12","author":"Duca","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.smim.2025.101981_bib152","doi-asserted-by":"crossref","first-page":"2829018","DOI":"10.1155\/2016\/2829018","article-title":"Depressive and anxiety disorders in systemic lupus erythematosus patients without major neuropsychiatric manifestations","volume":"2016","author":"Bai","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.smim.2025.101981_bib153","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12888-022-04236-z","article-title":"A cross-sectional study on the association of anxiety and depression with the disease activity of systemic lupus erythematosus","volume":"22","author":"Liao","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.smim.2025.101981_bib154","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.40591","article-title":"Review: nervous system disease in systemic lupus erythematosus: current status and future directions","volume":"71","author":"Hanly","year":"2019","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib155","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1093\/rheumatology\/keab160","article-title":"Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre","volume":"60","author":"Abrol","year":"2021","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.smim.2025.101981_bib156","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/ken260","article-title":"Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease","volume":"47","author":"Pego-Reigosa","year":"2008","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.smim.2025.101981_bib157","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.40764","article-title":"Psychosis in systemic lupus erythematosus: results from an international inception cohort study","volume":"71","author":"Hanly","year":"2019","journal-title":"Arthritis Rheumatol. Hoboken Nj"},{"key":"10.1016\/j.smim.2025.101981_bib158","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s12035-015-9090-9","article-title":"The Neuro-Immune pathophysiology of central and peripheral fatigue in systemic Immune-Inflammatory and Neuro-Immune diseases","volume":"53","author":"Morris","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.smim.2025.101981_bib159","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/rheumatology\/keae194","article-title":"Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project","volume":"64","author":"Sloan","year":"2025","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.smim.2025.101981_bib160","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/rheumatology\/39.11.1249","article-title":"The prevalence and associations of fatigue in systemic lupus erythematosus","volume":"39","author":"Tench","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.smim.2025.101981_bib161","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.smim.2025.101981_bib162","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/rheumatology\/keae216","article-title":"Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity","volume":"63","author":"Nikolopoulos","year":"2024","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.smim.2025.101981_bib163","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/art.27601","article-title":"The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib164","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0961203309102557","article-title":"Efficacy and safety of infliximab in active SLE: a pilot study","volume":"18","author":"Uppal","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/annrheumdis-2015-207654","volume":"75","author":"Merrill","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib166","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0961203316654767","article-title":"Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the phase 2 clinical trial with blisibimod","volume":"26","author":"Petri","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/PROM.S134326","article-title":"Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies","volume":"10","author":"Bangert","year":"2019","journal-title":"Patient Relat. Outcome Meas."},{"key":"10.1016\/j.smim.2025.101981_bib168","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/1756-185X.13081","article-title":"Sleep quality, clinical and psychological manifestations in women with systemic lupus erythematosus","volume":"20","author":"Moraleda","year":"2017","journal-title":"Int J. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib169","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/0961203316631630","article-title":"Insomnia symptoms, perceived stress and coping strategies in patients with systemic lupus erythematosus","volume":"25","author":"Palagini","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.smrv.2007.09.001","article-title":"Sleep and rheumatologic disorders","volume":"12","author":"Abad","year":"2008","journal-title":"Sleep. Med Rev."},{"key":"10.1016\/j.smim.2025.101981_bib171","doi-asserted-by":"crossref","first-page":"R1527","DOI":"10.1152\/ajpregu.00186.2006","article-title":"Effects of sleep deprivation on the development of autoimmune disease in an experimental model of systemic lupus erythematosus","volume":"291","author":"Palma","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.smim.2025.101981_bib172","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1523\/JNEUROSCI.2111-14.2014","article-title":"Sleep restriction impairs blood-brain barrier function","volume":"34","author":"He","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.smim.2025.101981_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104944","article-title":"Microglia dynamics in sleep\/wake states and in response to sleep loss","volume":"143","author":"Deurveilher","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.smim.2025.101981_bib174","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1523\/JNEUROSCI.3981-16.2017","article-title":"Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex","volume":"37","author":"Bellesi","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.smim.2025.101981_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2021.107559","article-title":"V. Effect of chronic sleep deprivation and sleep recovery on hippocampal CA3 neurons, spatial memory and anxiety-like behavior in rats","volume":"187","author":"Konakanchi","year":"2022","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.smim.2025.101981_bib176","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/pr.117.014647","article-title":"Neuroimmune axes of the blood-brain barriers and blood-brain interfaces: bases for physiological regulation, disease states, and pharmacological interventions","volume":"70","author":"Erickson","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.smim.2025.101981_bib177","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1111\/febs.13412","article-title":"The dynamic blood-brain barrier","volume":"282","author":"Keaney","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.smim.2025.101981_bib178","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri.2017.100","article-title":"Organ-specific protection mediated by cooperation between vascular and epithelial barriers","volume":"17","author":"Spadoni","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2025.101981_bib179","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/BOR.0000000000000682","article-title":"Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus","volume":"32","author":"Moore","year":"2020","journal-title":"Curr. Opin. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5387\/fms.2020-02","article-title":"Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers","volume":"66","author":"Sato","year":"2020","journal-title":"Fukushima J. Med. Sci."},{"key":"10.1016\/j.smim.2025.101981_bib181","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2147\/NDT.S359698","article-title":"Brain-Reactive antibodies are potential biomarkers for evaluating therapeutic efficacy in NPSLE patients","volume":"18","author":"Wang","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.smim.2025.101981_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal p autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.smim.2025.101981_bib183","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12915-020-00877-2","article-title":"Neuronal surface p antigen (NSPA) modulates postsynaptic NMDAR stability through ubiquitination of tyrosine phosphatase PTPMEG","volume":"18","author":"Espinoza","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.smim.2025.101981_bib184","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/WCO.0000000000000549","article-title":"Antibodies and the brain: antiribosomal p protein antibody and the clinical effects in patients with systemic lupus erythematosus","volume":"31","author":"Gonz\u00e1lez","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib185","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000281","article-title":"Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus","volume":"5","author":"Matsueda","year":"2018","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.smim.2025.101981_bib186","doi-asserted-by":"crossref","first-page":"eaai9111","DOI":"10.1126\/scitranslmed.aai9111","article-title":"Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica","volume":"9","author":"Shimizu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2025.101981_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011124","article-title":"Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis","volume":"5","author":"Lu","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.smim.2025.101981_bib188","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clim.2017.11.006","article-title":"Novel anti-suprabasin antibodies May contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus","volume":"193","author":"Ichinose","year":"2018","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.smim.2025.101981_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108980","article-title":"Measurement of anti-suprabasin antibodies, multiple cytokines and chemokines as potential predictive biomarkers for neuropsychiatric systemic lupus erythematosus","volume":"237","author":"Hoang","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101981_bib190","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/art.20156","article-title":"Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus","volume":"50","author":"Williams","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib191","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3109\/14397595.2015.1123345","article-title":"Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus","volume":"26","author":"Yamada","year":"2016","journal-title":"Mod. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib192","doi-asserted-by":"crossref","first-page":"R366","DOI":"10.1186\/ar1198","article-title":"Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies","volume":"6","author":"Conti","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2025.101981_bib193","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygeno.2004.03.010","article-title":"Identification of novel keratinocyte-secreted peptides dermokine-alpha\/-beta and a new stratified epithelium-secreted protein gene complex on human chromosome 19q13.1","volume":"84","author":"Matsui","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.smim.2025.101981_bib194","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S1568-9972(02)00063-0","article-title":"Antiendothelial cell antibodies in systemic lupus erythematosus","volume":"1","author":"Renaudineau","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.smim.2025.101981_bib195","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02207967","article-title":"Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases","volume":"11","author":"Nylander Lundqvist","year":"1992","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib196","doi-asserted-by":"crossref","first-page":"1111769","DOI":"10.3389\/fneur.2023.1111769","article-title":"The conundrum of neuropsychiatric systemic lupus erythematosus: current and novel approaches to diagnosis","volume":"14","author":"Emerson","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib197","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2017.04.008","article-title":"The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface","volume":"16","author":"Stock","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.smim.2025.101981_bib198","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.03.002","article-title":"Neuropsychiatric disease in murine lupus is dependent on the TWEAK\/Fn14 pathway","volume":"43","author":"Wen","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2025.101981_bib199","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-10-9","article-title":"TWEAK\/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier","volume":"10","author":"Stephan","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.smim.2025.101981_bib200","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/art.37745","article-title":"IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells","volume":"65","author":"Yoshio","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib201","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti\u2013NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib202","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/rheumatology\/keq408","article-title":"Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus","volume":"50","author":"Gono","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.smim.2025.101981_bib203","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ebiom.2015.05.027","article-title":"Selective impairment of spatial cognition caused by autoantibodies to the N-Methyl-D-Aspartate receptor","volume":"2","author":"Chang","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.smim.2025.101981_bib204","unstructured":"Kowal, C. et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment."},{"key":"10.1016\/j.smim.2025.101981_bib205","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"103","author":"Huerta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.smim.2025.101981_bib206","doi-asserted-by":"crossref","first-page":"18569","DOI":"10.1073\/pnas.1006980107","article-title":"Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms","volume":"107","author":"Faust","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2025.101981_bib207","series-title":"in Systemic Lupus Erythematosus","first-page":"307","article-title":"Chapter 36 - pathogenesis of tissue injury in the brain in patients with systemic lupus erythematosus","author":"Volpe","year":"2016"},{"key":"10.1016\/j.smim.2025.101981_bib208","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/jcbfm.2014.85","article-title":"Regional brain metabolism in a murine systemic lupus erythematosus model","volume":"34","author":"Vo","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.smim.2025.101981_bib209","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1084\/jem.20180776","article-title":"Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors","volume":"215","author":"Nestor","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2025.101981_bib210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41590-024-01772-6","article-title":"Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression","volume":"25","author":"Carroll","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2025.101981_bib211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti\u2013N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib212","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib213","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib214","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib216","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of Anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.smim.2025.101981_bib217","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00129","article-title":"Brain Renin-Angiotensin system and microglial polarization: implications for aging and neurodegeneration","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.smim.2025.101981_bib218","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0197-4580(00)00259-1","article-title":"Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer\u2019s dementia","volume":"22","author":"Savaskan","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.smim.2025.101981_bib219","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/sj.gene.6363907","article-title":"Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: analysis of 644 SLE families","volume":"3","author":"Parsa","year":"2002","journal-title":"Genes Immun."},{"key":"10.1016\/j.smim.2025.101981_bib220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0961203311418268","article-title":"Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus","volume":"21","author":"Abbas","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib221","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1470320312459979","article-title":"Association between the angiotensin-converting enzyme insertion\/deletion polymorphism and susceptibility to systemic lupus erythematosus: a meta-analysis","volume":"14","author":"Lee","year":"2013","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.smim.2025.101981_bib222","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/ijms19030876","article-title":"Within the brain: the renin angiotensin system","volume":"19","author":"Jackson","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.smim.2025.101981_bib223","unstructured":"Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia ."},{"key":"10.1016\/j.smim.2025.101981_bib224","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000923","article-title":"Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE","volume":"10","author":"Dobrowolski","year":"2023","journal-title":"Lupus Sci. Med"},{"key":"10.1016\/j.smim.2025.101981_bib225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.1780080205","article-title":"Antibody to ribosomes in systemic lupus erythematosus","volume":"8","author":"Sturgill","year":"1965","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2025.101981_bib226","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/0961203314555538","article-title":"Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus","volume":"24","author":"Massardo","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib227","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08916930400022699","article-title":"Anti-ribosomal p protein antibodies","volume":"38","author":"Gerli","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.smim.2025.101981_bib228","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/WCO.0000000000001054","article-title":"Progress in the mechanism of neuronal surface p antigen modulating hippocampal function and implications for autoimmune brain disease","volume":"35","author":"Barake","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib229","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2025.101981_bib230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.38900","article-title":"Anti\u2013Ribosomal p protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice","volume":"67","author":"Bravo-Zehnder","year":"2015","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib231","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by anti-ribosomal p antibodies via the limbic system","volume":"56","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"24","key":"10.1016\/j.smim.2025.101981_bib232","article-title":"Exploring Immune-Mediated brain function abnormalities in systemic lupus erythematosus: neuroimaging evidence of the impact of Anti-Ribosomal p protein antibodies","volume":"S1076-6332","author":"Liang","year":"2024","journal-title":"Acad. Radio."},{"key":"10.1016\/j.smim.2025.101981_bib233","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/ana.25908","article-title":"Absence of neuronal autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"88","author":"Varley","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.smim.2025.101981_bib234","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR t cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2025.101981_bib235","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/S0140-6736(24)02265-7","article-title":"Treatment of CNS systemic lupus erythematosus with CD19 CAR t cells","volume":"404","author":"Hagen","year":"2024","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.smim.2025.101981_bib236","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-Cell therapy in autoimmune disease - a case series with Follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2025.101981_bib237","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.cell.2023.10.001","article-title":"Chimeric autoantibody receptor t cells deplete NMDA receptor-specific b cells","volume":"186","author":"Reincke","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.smim.2025.101981_bib238","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/432595","article-title":"Inflammatory cytokines in systemic lupus erythematosus","volume":"2011","author":"Ohl","year":"2011","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.smim.2025.101981_bib239","article-title":"Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus","volume":"2010","author":"Okamoto","year":"2010","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.smim.2025.101981_bib240","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yfrne.2011.12.002","article-title":"Cytokines and brain excitability","volume":"33","author":"Galic","year":"2012","journal-title":"Front. Neuroendocr."},{"key":"10.1016\/j.smim.2025.101981_bib241","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2025.101981_bib242","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2016.11.039","article-title":"Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review","volume":"209","author":"Machado","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.smim.2025.101981_bib243","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0278-5846(01)00324-4","article-title":"Interferon alpha (IFN\u03b1) and psychiatric syndromes: a review","volume":"26","author":"Schaefer","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.smim.2025.101981_bib244","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13075-019-1985-9","article-title":"Interferon-\u03b1 exacerbates neuropsychiatric phenotypes in lupus-prone mice","volume":"21","author":"Zeng","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2025.101981_bib245","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2220\/biomedres.38.371","article-title":"Cognitive impairment with interferon treatment in patients with chronic hepatitis c","volume":"38","author":"Tanaka","year":"2017","journal-title":"Biomed. Res."},{"key":"10.1016\/j.smim.2025.101981_bib246","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbi.2015.12.011","article-title":"Interferon-\u03b1 acutely impairs whole-brain functional connectivity network architecture \u2013 a preliminary study","volume":"58","author":"Dipasquale","year":"2016","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.smim.2025.101981_bib247","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/sj.npp.1301362","article-title":"Basal ganglia hypermetabolism and symptoms of fatigue during Interferon-\u03b1 therapy","volume":"32","author":"Capuron","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.smim.2025.101981_bib248","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0961203316629556","article-title":"IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus","volume":"25","author":"Yoshio","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.smim.2025.101981_bib249","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000808","article-title":"Associations between circulating interferon and kynurenine\/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE","volume":"9","author":"Anderson","year":"2022","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.smim.2025.101981_bib250","doi-asserted-by":"crossref","first-page":"15496","DOI":"10.1016\/S0021-9258(18)82284-0","article-title":"A mechanism for increased quinolinic acid formation following acute systemic immune stimulation","volume":"268","author":"Saito","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2025.101981_bib251","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.smim.2025.101981_bib252","series-title":"Inflammation-Associated Depression: Evidence, Mechanisms and Implications","first-page":"249","article-title":"Role of kynurenine metabolism pathway activation in major depressive disorders","author":"Savitz","year":"2017"},{"key":"10.1016\/j.smim.2025.101981_bib253","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-170485","article-title":"Kynurenine pathway metabolites in Alzheimer\u2019s disease","volume":"60","author":"Giil","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib254","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.smim.2025.101981_bib255","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.smim.2025.101981_bib256","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125109","article-title":"Type I Interferon-Mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus","volume":"10","author":"Lood","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2025.101981_bib257","first-page":"850","article-title":"Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations","volume":"23","author":"Vogelgesang","year":"1996","journal-title":"J. Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib258","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000559","article-title":"Quinolinic acid, a kynurenine\/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus","volume":"8","author":"Anderson","year":"2021","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.smim.2025.101981_bib259","first-page":"16658","article-title":"Role of IL-1\u03b2, IL-6, IL-8 and IFN-\u03b3 in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.smim.2025.101981_bib260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/acr2.11217","article-title":"Role of serum IL-6 in neuropsychiatric systemic lupus erythematosus","volume":"3","author":"Hirohata","year":"2021","journal-title":"ACR Open Rheuma"},{"key":"10.1016\/j.smim.2025.101981_bib261","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186414","article-title":"Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus","volume":"12","author":"Asano","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2025.101981_bib262","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00004647-200006000-00008","article-title":"Ischemia-Induced Interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA Receptor-Mediated excitoxicity in the brain","volume":"20","author":"Ali","year":"2000","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.smim.2025.101981_bib263","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.smim.2025.101981_bib264","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-024-03085-9","article-title":"Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL\/lpr mouse model of neuropsychiatric lupus","volume":"21","author":"Reynolds","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.smim.2025.101981_bib265","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.smim.2025.101981_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155640","article-title":"A review on the role of chemokines in the pathogenesis of systemic lupus erythematosus","volume":"146","author":"Ghafouri-Fard","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.smim.2025.101981_bib267","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/ard-2023-224689","article-title":"Characterisation of choroid plexus-infiltrating t cells reveals novel therapeutic targets in murine neuropsychiatric lupus","volume":"83","author":"Moore","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2025.101981_bib268","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00487","article-title":"A distinct t follicular helper cell subset infiltrates the brain in murine neuropsychiatric lupus","volume":"9","author":"Jain","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:35:07Z","timestamp":1759350907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532325000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":268,"alternative-id":["S1044532325000533"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2025.101981","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffuse neuropsychiatric lupus: Clinical evidence, immune-mediated mechanisms, and therapeutic insights","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2025.101981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101981"}}